Infectious morbidity in pediatric patients receiving neoadjuvant chemotherapy for sarcoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cancers 13.2021, 9, art. 1990, doi:10.3390/cancers13091990, ISSN 2072-6694
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2021
- Creator
-
Willmer, Denise
Zöllner, Stefan
Schaumburg, Frieder
Jürgens, Heribert
Lehrnbecher, Thomas
Groll, Andreas H.
- URN
-
urn:nbn:de:hebis:30:3-621326
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Willmer, Denise
- Zöllner, Stefan
- Schaumburg, Frieder
- Jürgens, Heribert
- Lehrnbecher, Thomas
- Groll, Andreas H.
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2021
Other Objects (12)
Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Travel and migration associated infectious diseases morbidity in Europe, 2008
Neoadjuvant chemotherapy for primary sarcoma of the breast: a case report
Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma
Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity after Gastrectomy for Gastric Cancer
Thrombotic and Infectious Morbidity Are Associated with Transfusion in Posterior Spine Fusion
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
The demographic and morbidity characteristics of a population receiving food support in Israel
Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Travel and migration associated infectious diseases morbidity in Europe, 2008
Neoadjuvant chemotherapy for primary sarcoma of the breast: a case report
Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma
Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity after Gastrectomy for Gastric Cancer
Thrombotic and Infectious Morbidity Are Associated with Transfusion in Posterior Spine Fusion
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
The demographic and morbidity characteristics of a population receiving food support in Israel
Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Travel and migration associated infectious diseases morbidity in Europe, 2008
Neoadjuvant chemotherapy for primary sarcoma of the breast: a case report
Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma
Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity after Gastrectomy for Gastric Cancer
Thrombotic and Infectious Morbidity Are Associated with Transfusion in Posterior Spine Fusion
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment